OQROGet OQRO Pro
Insider trade

Twist Bioscience (TWST)President and COO sold ~$56K

Patrick John Finn, President and COO at Twist Bioscience, sold ~$56K of Twist Bioscience shares.

~$56K
Approx. value · 1,877 sh @ $29.75
241K
Holds after · shares reported
Traded
May 21, 2025
Filed
May 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 20, 2025Insider · 3 peopleInsiders: 3 sales (~$94K)
  2. Apr 2, 2025Insider · 4 peopleInsiders: 4 sales (~$37K)
  3. Apr 9, 2025InsiderCFO sold ~$89K of TWST shares in the open market
  4. Apr 23, 2025InsiderOfficer sold ~$82K of TWST shares in the open market
  5. May 5, 2025Insider · 5 peopleInsiders: 5 sales (~$369K)
  6. May 7, 2025InsiderOfficer sold ~$164K of TWST shares in the open market
  7. May 8, 2025InsiderOfficer sold ~$646K of TWST shares in the open market
  8. May 21, 2025 · this disclosureInsiderOfficer sold ~$56K of TWST shares in the open market

What came next

  1. May 21, 2025Insider · 5 peopleInsiders: 5 sales (~$153K)
  2. May 23, 2025InsiderOfficer sold ~$23K of TWST shares in the open market
  3. Jun 6, 2025Insider · 4 peopleInsiders: 4 sales (~$111K)
  4. Jun 16, 2025InsiderOfficer sold ~$3.1K of TWST shares in the open market
  5. Jun 20, 2025Insider · 3 peopleInsiders: 3 sales (~$79K)
  6. Jul 2, 2025Insider · 4 peopleInsiders: 4 sales (~$34K)
  7. Jul 9, 2025InsiderCFO sold ~$93K of TWST shares in the open market
  8. Jul 23, 2025InsiderOfficer sold ~$80K of TWST shares in the open market
  9. Aug 4, 2025Insider · 5 peopleInsiders: 5 sales (~$312K)
  10. Aug 21, 2025Insider · 6 peopleInsiders: 6 sales (~$178K)
  11. Aug 25, 2025InsiderOfficer sold ~$24K of TWST shares in the open market
  12. Sep 8, 2025Insider · 4 peopleInsiders: 4 sales (~$94K)
  13. Sep 15, 2025InsiderOfficer sold ~$2.4K of TWST shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Twist Bioscience

For Twist Bioscience, OQRO holds 36 insider filings (SEC Form 4 or Form 144), 11 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TWST page.

Other recent filings by Patrick John Finn, President and COO

The full history of Patrick John Finn, President and COO is on the profile page.

How this filing works

Other disclosures at Twist Bioscience

Everything OQRO holds on this company is on its TWST page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data